Clinical trial
Study of a Large Protein Molecule Administered With Escalating Doses of…
NCT00369187 · Halozyme Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00369187 |
|---|---|
| Title | Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase |
| Lead sponsor | Halozyme Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | large protein molecule |
| Enrollment | 15 |
| Start date | Jul 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Aug 29, 2006 |
| Last update posted | Jan 10, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: